Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Genmab
Genmab
Genmab axes an ADC development program after the data fail to impress
Endpoints
Tue, 11/24/20 - 11:18 pm
Genmab
antibody-drug conjugate
enapotamab vedotin
J&J's Darzalex Proves Effective in Yet Another Multiple Myeloma Indication
BioSpace
Thu, 10/22/20 - 11:01 pm
JNJ
Genmab
clinical trials
Darzalex
Multiple Myeloma
J&J’s next-gen Darzalex sparks drug delivery royalties battle
Fierce Pharma
Thu, 09/24/20 - 11:32 pm
JNJ
Darzalex
Genmab
Halozyme
Genmab and Janssen Head to Arbitration Table Over Darzalex Royalties
BioSpace
Wed, 09/23/20 - 10:22 am
Genmab
JNJ
Janssen
Darzalex
arbitration
Multiple Myeloma
Seattle Genetics/Genmab's tisotumab’s cervical cancer efficacy falls off
EP Vantage
Tue, 06/30/20 - 10:34 am
cervical cancer
tisotumab vedotin
Genmab
Seattle Genetics
clinical trials
AbbVie to pay Genmab $750M upfront to form bispecific R&D pact
Fierce Biotech
Wed, 06/10/20 - 11:01 am
AbbVie
bispecific antibodies
cancer
Genmab
Regeneron
epcoritamab
Upcoming events – Genmab's route to market, and late-stage data for Zogenix
EP Vantage
Fri, 01/24/20 - 10:50 am
Genmab
tisotumab vedotin
cervical cancer
Zogenix
Fintepla
Lennox-Gastaut Syndrome
A Look at 5 Big and Interesting Biotech IPOs for 2019
BioSpace
Fri, 12/20/19 - 12:36 pm
IPOs
NASDAQ
Adaptive Biotechnologies
Genmab
Gossamer Bio
BridgeBio
Alector
[video] Genmab IPO raises $582m, becoming second largest US IPO ever by a bio-tech company
Yahoo Finance
Wed, 09/11/19 - 09:51 am
Genmab
IPOs
cancer
Mark Your Calendar For These September PDUFA Dates
Yahoo/Benzinga
Wed, 08/28/19 - 12:53 pm
FDA
Roche
Celgene
Tecentriq
Xeris Pharmaceuticals
Gvoke
Ardelyx
tenapanor
Merck
Pifeltro
Delstrigo
Novo Nordisk
semaglutide
JNJ
Genmab
daratumumab
Invokana
Denmark's Genmab hits the jackpot with $500M+ US IPO as smaller biotechs rake in a combined $147M
Endpoints
Thu, 07/18/19 - 10:12 am
Genmab
IPOs
cancer
The Week Ahead In Biotech: Johnson & Johnson Kickstarts Big Pharma Earnings
Yahoo/Benzinga
Sun, 07/14/19 - 04:09 pm
Merck
relebactam
TapImmune
earnings
JNJ
Seattle Genetics
Abbott Labs
Intuitive Surgical
Mirum Pharmaceuticals
Fulcrum Therapeutics
Genmab
Genmab steps up for a $500M IPO haul, with its sights on a record-setting market cap
Endpoints
Wed, 07/10/19 - 10:49 am
Genmab
IPOs
NASDAQ
J&J bags $150M option on Genmab's Darzalex successor
Fierce Biotech
Tue, 06/11/19 - 09:34 am
Genmab
JNJ
Darzalex
Multiple Myeloma
drug development
Genmab files for $500M IPO to fund multi-front cancer R&D push
Fierce Biotech
Wed, 05/29/19 - 10:02 am
Genmab
IPOs
antibody-drug conjugate
cervical cancer
MorphoSys Settles Patent Lawsuit with Janssen and Genmab
CP Wire
Fri, 02/1/19 - 09:44 am
MorphoSys
Janssen
Genmab
daratumumab
patents
MorphoSys Settles Patent Lawsuit with Janssen and Genmab
Fri, 02/1/19 - 09:43 am
MorphoSys
Janssen
Genmab
patent lawsuits
patents
Darazalex
MorphoSys Patents Ruled Invalid in Patent Lawsuit Against Janssen and Genmab
CP Wire
Mon, 01/28/19 - 11:02 am
MorphoSys
Janssen
Genmab
patents
MorphoSys Patents Ruled Invalid in Patent Lawsuit Against Janssen and Genmab
Mon, 01/28/19 - 10:10 am
MorphoSys
Janssen
Genmab
Genmab's blockbuster Darzalex surpasses $2B in sales
BioCentury
Tue, 01/8/19 - 11:40 pm
Genmab
Multiple Myeloma
Darzalex
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »